| Literature DB >> 35683124 |
Noor Ul Huda Altaf1, Muhammad Yasin Naz1, Shazia Shukrullah1, Madiha Ghamkhar2, Muhammad Irfan3, Saifur Rahman3, Tomasz Jakubowski4, Esam A Alqurashi5, Adam Glowacz6, Mater H Mahnashi7.
Abstract
An environmentally friendly non-thermal DC plasma reduction route was adopted to reduce Ag+ ions at the plasma-liquid interface into silver nanoparticles (AgNPs) under statistically optimized conditions for biological and photocatalytic applications. The efficiency and reactivity of AgNPs were improved by statistically optimizing the reaction parameters with a Box-Behnken Design (BBD). The size of the AgNPs was chosen as a statistical response parameter, while the concentration of the stabilizer, the concentration of the silver salt, and the plasma reaction time were chosen as independent factors. The optimized parameters for the plasma production of AgNPs were estimated using a response surface methodology and a significant model p < 0.05. The AgNPs, prepared under optimized conditions, were characterized and then tested for their antibacterial, antioxidant, and photocatalytic potentials. The optimal conditions for these three activities were 3 mM of stabilizing agent, 5 mM of AgNO3, and 30 min of reaction time. Having particles size of 19 to 37 nm under optimized conditions, the AgNPs revealed a 82.3% degradation of methyl orange dye under UV light irradiation. The antibacterial response of the optimized AgNPs against S. aureus and E. coli strains revealed inhabitation zones of 15 mm and 12 mm, respectively, which demonstrate an antioxidant activity of 81.2%.Entities:
Keywords: antioxidant activity; plasma reduction reaction; response surface methodology; silver nanoparticles; wastewater treatment
Year: 2022 PMID: 35683124 PMCID: PMC9181389 DOI: 10.3390/ma15113826
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.748
Figure 1Schematic diagram of plasma synthesized AgNPs.
Coded values with experimental and predicted responses obtained from a Box–Behnken experimental design.
| Runs | A | B | C | Y = Size of AgNPs (nm) Experimental | Predicted |
|---|---|---|---|---|---|
| 1 | 0 | 1 | 1 | 23.05 | 25.07 |
| 2 | 1 | 0 | 1 | 21.40 | 21.5 |
| 3 | 0 | 0 | 0 | 36.45 | 37 |
| 4 | 0 | −1 | 1 | 19.89 | 20.38 |
| 5 | −1 | 0 | 1 | 26.60 | 25.32 |
| 6 | −1 | 0 | −1 | 33.45 | 34 |
| 7 | −1 | 1 | 0 | 25.33 | 24.5 |
| 8 | 1 | −1 | 0 | 28.00 | 28.2 |
| 9 | 0 | 0 | 0 | 32.60 | 32.3 |
| 10 | −1 | −1 | 0 | 26.88 | 27 |
| 11 | 0 | −1 | −1 | 30.40 | 31.2 |
| 12 | 1 | 1 | 0 | 20.22 | 19.8 |
| 13 | 1 | 0 | −1 | 25.33 | 24.5 |
| 14 | 0 | 0 | 0 | 25.55 | 22.36 |
| 15 | 0 | 1 | −1 | 32.02 | 31.33 |
Figure 2Main effects plot graph for the size of AgNPs.
Analysis of variance of quadratic model for AgNP synthesis.
| Source | Sum of Squares | Degree of Freedom | Mean Square | F-Value | Determination of Coefficient R2 | |
|---|---|---|---|---|---|---|
| Model | 306.989 | 9 | 34.10 | 16.039 | 0.002 | 0.96646 |
| Residual | 10.634 | 5 | 2.126 | |||
| Total | 317.623 | 14 |
Figure 3Normal and probability plot for experimental vs. predicted size of AgNPs.
Variables levels selected for Box–Behnken design.
| Variables | Main Effects | Coefficients | T-Value | Confidence | |
|---|---|---|---|---|---|
| Intercept | 461.962 | 230.981 | 4.441 | 0.000 | 100 |
|
| –100.416 | –50.208 | –4.017 | 0.010 | 99.12 |
|
| –2.002 | –1.00097 | –2.061 | 0.094 | 91.40 |
|
| –5.791 | 2.895 | 1.762 | 0.138 | 86.06 |
|
| –0.084 | –0.042 | –0.869 | 0.424 | 58.14 |
|
| −1.597 | –0.798 | –4.560 | 0.005 | 99.343 |
|
| −0.00059 | –0.00029 | –0.026 | 0.980 | 1.99 |
|
| 7.099 | 3.549 | 4.602 | 0.004 | 99.49 |
|
| 0.040 | 0.0201 | 5.105 | 0.002 | 99.67 |
|
| 0.448 | 0.224 | 3.309 | 0.021 | 98.14 |
Figure 4(a–c): 3D surface plot showing the effect of process parameters on the size of AgNPs.
Figure 5XRD spectra of statistical analyzed AgNPs (runs 1, 2, 12 and 4).
Figure 6Variation in the UV-absorption peak with different process parameters.
Figure 7(a) SEM micrograph of run 4 (small-sized AgNPs), (b) SEM image of run 6 (large-sized AgNPs).
Figure 8(a,b) Size distribution histogram of AgNPs.
Mean particle size obtained by XRD and SEM analysis.
| Sample Code | Average Particle Size (nm) by XRD Analysis | Average Particle Size (nm) by SEM Analysis |
|---|---|---|
| Run 4 | 19.89 | 82 |
| Run 6 | 33.45 | 102 |
Figure 9EDX spectra of optimized AgNPs (run 4).
Figure 10FTIR spectrum of optimized (run 4) AgNPs.
Figure 11(a,b) The images represent the antibacterial activity of optimized AgNPs against Gram +ive and Gram −ive bacterial strains.
The antibacterial activities and zones of inhibition of optimized AgNPs.
| Samples | Size of AgNPs (nm) | Inhibition Zone (mm) |
|
|---|---|---|---|
| S1 (Run 1) | 23.05 | 5 | 8 |
| S2 (Run 2) | 21.40 | 6 | 10 |
| S3 (Run 12) | 20.22 | 9 | 12 |
| S4 (Run 4) | 19.89 | 12 | 18 |
Figure 12Graph shows the maximum zone of inhibition against the E. coli bacterial strains.
Figure 13DPPH scavenging activity of optimized AgNPs, with different concentrations of vitamin C for comparison.
Figure 14(a) Absorbance spectra of an aqueous solution of MO dye treated with (run 4) optimized AgNPs at 100 min of irradiation, (b)% of dye degradation at different time intervals, (c) image of 0 min and 100 min degradation of MO.
Summary of AgNPs-based applications depending on their properties.
| Sr No | Material | Method | Size/Shape/Structure | Antibacterial | Antioxidant | Photocatalytic | Reference |
|---|---|---|---|---|---|---|---|
| 1 | Glucose stabilized AgNPs | Plasma reduction method | Size: 19.89 by XRD | Antioxidant activity enhanced with rising amount of salt concentration by DPPH assay | 82.3% MO | Present study | |
| 2 | fugus Trichoderma harzianum synthesis of extracellular AgNPs | Green synthesis | Size: 21.49 nm by DLS | Remarkable antioxidant | - | [ | |
| 3 | AgNPs@SEE | biosynthesis | Size: 35–50 nm | - | MO degrade 95.89% | [ | |
| 4 | AgNPs) using Carissa opaca leaves | Green approach | Size: 8 nm | Better antioxidant activity by DPPH assay | 97% of MB in 50 min | [ | |
| 5 | chitosan/silver (CS/Ag) nanocomposite | bio-inspired method | Size: 23–78 nm | Vitro antioxidant by DPPH | 88% MB in 220 min | [ | |
| 6 | AgNPs | Biosynthesis method | Size: 30 nm | Highest antibacterial activity against | Antioxidant by DPPH and H2O2 assay | - | [ |
| 7 | AgNPs | Chemical route | Size: 4, 12 and 40 nm | - | - | [ | |
| 8 | AgNPs | Green synthesis | Size: 30 nm by SEM analysis | Higher antioxidant activity using TFC, TPC, TAC, DPPH, FRAP, and IC50 assays | MO degradation in 20 min | [ | |
| 9 | AgNPs | Bio synthesis | Size: 39 ± 4 nm | Gram-negative | Potential antioxidant activity by using DPPH | - | [ |
| 10 | AgNPs | Green synthesis by using stem (S), root (R), and leaf (L) | Size: S = 25.55 nm, | - | - | MV, S, EMB | [ |